Clinical Trial Update: Prescription and Persistence of Antithrombotic Agents in Acute Ischemic Stroke or Transient Ischemic Attack Patients With MCA(Middle Cerebral Artery) Disease

View source ↗

Summary

This clinical trial update analyzes prescription patterns and persistence of antithrombotic therapy in patients with middle cerebral artery disease following ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Middle Cerebral Artery Dissection
• Stroke
• Transient Ischemic Attack

Snippet

Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: MCA - Middle Cerebral Artery Dissection | Status: UNKNOWN